Get the Stockscreener App
2.15
2.27%
-0.05
Pre-market:
2.29
0.14
+6.51%
Palisade Bio Inc stock is traded at $2.15, with a volume of 1.31M.
It is down -2.27% in the last 24 hours and down -3.59% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$2.20
Open:
$2.18
24h Volume:
1.31M
Relative Volume:
0.15
Market Cap:
$320.79M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.1537
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
+17.49%
1M Performance:
-3.59%
6M Performance:
+201.20%
1Y Performance:
+21.47%
1-Day Range:
$2.1021
$2.18
1-Week Range:
$1.93
$2.30
52-Week Range:
$0.53
$2.59
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
2.15 | 328.25M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palisade Bio Inc Stock (PALI) Latest News
Palisade Bio (PALI) soars 5% ahead of clinical trial results - MSN
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Palisade Bio (PALI) Soars 5% Ahead of Clinical Trial Results - Finviz
10 Stocks Lighting Up Market Ahead of Christmas - Insider Monkey
Palisade Bio: Gut Prodrug For IBD With Catalysts - Seeking Alpha
Palisade Bio (PALI) upgraded to buy: Here's what you should know - MSN
Aug Summary: Is Palisade Bio Inc stock ready for breakout2025 Macro Impact & AI Enhanced Market Trend Forecasts - moha.gov.vn
Published on: 2025-12-21 10:03:36 - Улправда
How currency fluctuations impact Palisade Bio Inc. stock2025 Historical Comparison & Weekly Watchlist of Top Performers - Улправда
Why analysts remain bullish on Palisade Bio Inc. stock2025 Top Gainers & High Accuracy Investment Signals - Улправда
Will Palisade Bio Inc. stock benefit from sector rotationQuarterly Performance Summary & AI Forecasted Entry and Exit Points - Улправда
What earnings margins imply for Palisade Bio Inc. (7NS0) stockPortfolio Gains Summary & Weekly Top Stock Performers List - Улправда
Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Can Palisade Bio Inc. stock deliver surprise earnings beatWatch List & High Return Stock Watch Alerts - Улправда
How Palisade Bio Inc. stock reacts to bond yields2025 Performance Recap & Daily Entry Point Trade Alerts - Улправда
Is Palisade Bio Inc. stock a good choice for value investorsJuly 2025 Pullbacks & Low Risk Investment Opportunities - Улправда
Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Aug Macro: How geopolitical risks impact Palisade Bio Inc. (7NS0) stock2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - Улправда
Retail Trends: Will Palisade Bio Inc. stock benefit from sector rotation2025 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - Улправда
Is Palisade Bio Inc. stock near bottom after decline2025 Trade Ideas & Smart Allocation Stock Tips - Улправда
Aug Final Week: Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
How interest rate cuts could boost Palisade Bio Inc. stockTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Aug Opening: How geopolitical risks impact Palisade Bio Inc. (7NS0) stockMarket Growth Summary & Low Drawdown Momentum Ideas - Улправда
Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Big Picture & High Conviction Investment Ideas - Улправда
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Palisade Bio Inc - GuruFocus
Palisade Bio approves key proposals at stockholder meeting - MSN
Palisade Bio Stock Soars as Clinical Workforce Expands with New VP Appointment - StocksToTrade
Palisade Bio Stock Surge: What’s Behind the Rise? - StocksToTrade
Palisade Bio’s Vice President Appointment and UC Trial Success Boost Confidence - timothysykes.com
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision - ts2.tech
Palisade Bio (NASDAQ:PALI) Trading Up 0.6%Here's What Happened - MarketBeat
Palisade Bio (NASDAQ:PALI) Trading Up 0.6% – Here’s What Happened - Defense World
How does Palisade Bio Inc (PALI) change from a tortoise to a hare? - setenews.com
Retail Surge: What earnings margins imply for Palisade Bio Inc 7NS0 stock2025 Macro Impact & AI Based Buy/Sell Signal Reports - moha.gov.vn
Palisade Bio prices 171.4M shares at 70c in upsized underwritten public offering - MSN
EBIT per share of Palisade Bio, Inc. – MUN:7NS0 - TradingView
Aug Mood: Is Palisade Bio Inc stock a good choice for value investorsJuly 2025 Outlook & Expert Verified Stock Movement Alerts - moha.gov.vn
Is Palisade Bio Inc. stock ready for breakoutQuarterly Portfolio Summary & Growth-Oriented Investment Plans - Newser
Palisade Bio increases authorized common shares following stockholder approval By Investing.com - Investing.com Nigeria
Palisade Bio increases authorized common shares following stockholder approval - Investing.com
Is Palisade Bio Inc. stock a buy before product launchesEarnings Beat & Weekly High Conviction Trade Ideas - Newser
How Palisade Bio Inc. (7NS0) stock correlates with oil markets2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Will Palisade Bio Inc. stock beat EPS estimates2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser
Will Palisade Bio Inc. (7NS0) stock profit from AI boomGlobal Markets & Reliable Intraday Trade Plans - Newser
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development - markets.businessinsider.com
Palisade Bio appoints James Izanec as VP of clinical development By Investing.com - Investing.com Australia
PALI SEC FilingsPalisade Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Palisade Bio appoints James Izanec as VP of clinical development - Investing.com
Palisade Bio Appoints Dr. James Izanec as Vice President of Clinical Development - Quiver Quantitative
Palisade Bio strengthens clinical leadership team with appointment of James Izanec - marketscreener.com
Palisade Bio Strengthens Clinical Leadership Team with - GlobeNewswire
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):